Ipsen 2015 Financial Results – Full Year Earnings

Ipsen presented its 2015 full-year financial results covering revenue performance, operational highlights, and strategic initiatives including the cabozantinib in-licensing agreement. The presentation reviews 2015 financial performance alongside the company's therapeutic portfolio and market outlook.